Broad deployment of expanded HD medium-cutoff dialyzers across DaVita's U.S. network over the coming quarters, after securing supply.
Raised 2026 U.S. treatment-volume outlook to 25-50 basis points and increased adjusted operating income and EPS guidance after Q1 outperformance.
Elara Caring home-health partnership expected to provide a small benefit to other income in 2026 and support dialysis-tailored home care.
Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for DaVita Inc. and 4,900+ companies.